Mario Medvedovic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

United statesUniversity of cincinnatiLalanthica yogendranShesh raiRekha chaudharyPankaj desaiBiplab dasguptaGary gudelskyMario medvedovicCatalyst research awardUc jamesl winkle college of pharmacyFalk medical researchClinical cancer researchUniversity of cincinnati cancer centerDivision of hematology oncologyBrain tumor center